| Bioactivity | Tyr3-Octreotate is a somatostatin analog. Tyr3-Octreotate exhibits high uptake into tumor, that is capable to be labeled with radioactive metal and thus exhibits antitumor efficacy[1]. |
| CAS | 302794-43-0 |
| Sequence | {d-Phe}-Cys-Tyr-{d-Trp}-Lys-Thr-Cys-Thr (Disulfide bridge: Cys2-Cys7) |
| Shortening | {d-Phe}-CY-{d-Trp}-KTCT (Disulfide bridge: Cys2-Cys7) |
| Formula | C49H64N10O12S2 |
| Molar Mass | 1049.22 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Capello A, et al., Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro. Cancer Biother Radiopharm. 2003 Oct;18(5):761-8. |
Tyr3-Octreotate
CAS: 302794-43-0 F: C49H64N10O12S2 W: 1049.22
Tyr3-Octreotate is a somatostatin analog. Tyr3-Octreotate exhibits high uptake into tumor, that is capable to be labeled
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.